[Dasabuvir/ombitasvir/paritaprevir/ritonavir (Addendum to Commissions A15-03 and A15-04)]

Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018003086
German
Original Title: Dasabuvir Ombitasvir/Paritaprevir/Ritonavir (Addendum zu den Aufträgen A15-03 und A15-04)
Details
Project Status: Completed
Year Published: 2015
English language abstract: There is no English language summary available
Publication Type: Full HTA
Country: Germany
MeSH Terms
  • Hepatitis C, Chronic
  • Ritonavir
  • Antiviral Agents
  • Hepatitis C
  • Anilides
  • Sulfonamides
  • Cyclopropanes
  • HIV Protease Inhibitors
Keywords
  • Dasabuvir
  • Ombitasvir
  • Paritaprevir
  • Ritonavir
  • Hepatitis C - Chronic
  • Benefit Assessment
Contact
Organisation Name: Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address: IQWiG, Im Mediapark, 8, DE-50670 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email: berichte@iqwig.de
Copyright: Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.